Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 63249.11 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 30-09-2020, the company reported a Consolidated sales of Rs 4972.58 Crore, up 16.27 % from last quarter Sales of Rs 4276.89 Crore and up 16.61 % from last year same quarter Sales of Rs 4264.24 Crore Company reported net profit after tax of Rs 661.85 Crore in latest quarter.
Investment Rationale
The brokerage values CIPLA at 22x 12M forward earnings to arrive at TP of INR815. It maintains Neutral on limited upside from current levels.
Promoter/FII Holdings
Promoters held 36.6 per cent stake in the company as of Sept 30, 2020, while FIIs held 20.2 per cent, DIIs 19.7 per cent and public and other 23.5 per cent.